| Product Name : |
TACROLIMUS-13C,D2 |
| Purity/ Specification : |
93.10 |
| CAS No. : |
1356841-89-8 |
| Molecular Formula : |
13CC43D2H67NO12 |
| CAT No : |
ALL-D01898 |
| Molecular Weight : |
807.02 |
| Chemical Name : |
TACROLIMUS-13C,D2 |
D-labelled analytical Standard.
Stable Isotope-Labelled Compounds for Pharmaceutical Research & Drug Development
Stable isotope-labelled compounds are indispensable tools in modern pharmaceutical research, supporting drug discovery, bioanalytical method development, pharmacokinetic (PK) studies, metabolism, toxicology, and bioequivalence testing. Isotopes such as Deuterium (²H), Carbon-13 (¹³C), Nitrogen-15 (¹⁵N), and Oxygen-18 (¹⁸O) enable highly accurate molecular tracking and quantitative analysis using advanced analytical techniques including LC-MS/MS and GC-MS.
At ALLMPUS Laboratories Pvt. Ltd., we specialize in the custom synthesis and global supply of high-purity stable isotope-labelled compounds for pharmaceutical, biotechnology, CRO, CDMO, and academic research organizations. Our expertise includes deuterium-labelled APIs, carbon-13 and nitrogen-15 labelled compounds, impurity standards, metabolite standards, and custom isotope synthesis tailored to client requirements.
Deuterium labelling has become increasingly important in drug development due to its ability to improve metabolic stability, reduce undesirable metabolism, optimize pharmacokinetic profiles, and support the development of next-generation therapeutics. Our isotope-labelled products are manufactured under stringent quality standards and supplied with comprehensive analytical documentation to meet regulatory and research requirements worldwide.
Whether you require isotope-labelled reference standards, custom synthesis, or specialized labelled molecules for analytical applications, ALLMPUS Laboratories delivers reliable, high-quality solutions with scientific expertise, rapid turnaround, and global shipping.
* Stable isotope-labelled compounds
* Deuterium-labelled compounds
* Carbon-13 labelled compounds
* Nitrogen-15 labelled compounds
* Isotope labelling
* Pharmaceutical research
* Drug development
* LC-MS/MS standards
* Pharmacokinetics
* Bioequivalence studies
* Custom synthesis
* Reference standards
* CRO/CDMO
* API impurity standards
* Tacrolimus-13C,D2 (FK506-13C,d2)
* deuterated-labelled products
* Tacrolimus,
* Tacrolimus (FK506),
* Fujimycin-13C,d2,
* tacrolimus Immunosuppressants,
* Stable isotope.
* analytical Standard